Eli Lilly & Co
LLY· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $5.77B | $5.44B | $6.15B | $5.65B |
| Net Income | $1.20B | $1.33B | $1.24B | $1.30B |
| EPS Diluted | $1.11 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $1.18 |
| $1.11 |
| $1.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.